摘要
在梳理近年国内外降脂中药研究成果的基础上,分别从降脂中药体外筛选模型、有效单体、复方和单味降脂中药以及降脂中成药等几个方面详细阐述降脂中药调控肝LDL-R基因表达的研究现状,使中药药理的作用靶点、作用环节及作用机理更加清楚,促进中药新药研究及临床疗效的提高和中医药理论的创新。
According to the research results of the lipid - lowering Chinese medicine at home and abroad in recent years ,the paper will elaborate on the research status of the antihyperlipidemia effects of chinese medicine from the aspects of its vitro screening model, effective monomer, compounding, single medlcine and antihyperlipidemia Traditional Chinese Medicine Patent Prescription treat the functions of low density lipoprotein receptor in rat liver, make the action target, link, and mechanism of the herbal pharmacology more clear, promote the new Chinese Herbal research, the improvement of the clinical efficient and the theory innovation of the traditional chinese medicine.
出处
《中华中医药学刊》
CAS
2007年第7期1382-1384,共3页
Chinese Archives of Traditional Chinese Medicine
基金
河南省科技攻关项目(国际合作项目)(0646630002)
关键词
中药
肝脏低密度脂蛋白受体
基因表达
综述
Chinese medicine
low density lipoprotein receptor in rat liver
gene expression
recapitulation
